RA Capital Management »

Scilex Holding shares owned by RA Capital Management

Quarter-by-quarter ownership of Scilex Holding (SCLX) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Scilex Holding

Tip: Access up to 7 years of quarterly data

All positions including Scilex Holding held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Scilex Holding by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $242k 261k 0.92
2024-06-30 $504k 261k 1.93

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH
Climb Bio SH (ELYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Scilex Holding

Armistice Capital
State Street Corporation
BlackRock
BlackRock
Vanguard Group
Geode Capital Management
Northern Trust
Citadel Advisors
D. E. Shaw & Co
Rafferty Asset Management
Citigroup
Henderson Group
Jpmorgan Chase & Co
RA Capital Management
Heights Capital Management

View all funds holding Scilex Holding